The aim of the present study was to explore whether hydrogen sulfide (H2S) protects against ischemic heart failure (HF) by inhibiting the necroptosis pathway. Mice were randomized into Sham, myocardial infarction (MI), MI + propargylglycine (PAG) and MI + sodium hydrosulfide (NaHS) group, respectively. The MI model was induced by ligating the left anterior descending coronary artery. PAG was intraperitoneally administered at a dose of 50 mg/kg/day for 4 weeks, and NaHS at a dose of 4 mg/kg/day for the same period. At 4 weeks after MI, the following were observed: A significant decrease in the cardiac function, as evidenced by a decline in ejection fraction (EF) and fractional shortening (FS); an increase in plasma myocardial injury markers, such as creatine kinase-MB (CK-MB) and cardiac troponin I (cTNI); an increase in myocardial collagen content in the heart tissues; and a decrease of H2S level in plasma and heart tissues. Furthermore, the expression levels of necroptosis-related markers such as receptor interacting protein kinase 1 (RIP1), RIP3 and mixed lineage kinase domain-like protein (MLKL) were upregulated after MI. NaHS treatment increased H2S levels in plasma and heart tissues, preserving the cardiac function by increasing EF and FS, decreasing plasma CK-MB and cTNI and reducing collagen content. Additionally, NaHS treatment significantly downregulated the RIP1/RIP3/MLKL pathway. While, PAG treatment aggravated cardiac function by activated the RIP1/RIP3/MLKL pathway. Overall, the present study concluded that H2S protected against ischemic HF by inhibiting RIP1/RIP3/MLKL-mediated necroptosis which could be a potential target treatment for ischemic HF.

Department of Clinical Diagnostics Hebei Medical University Shijiazhuang Hebei China

Zobrazit více v PubMed

Dunlay SM, Roger VL. Gender differences in the pathophysiology, clinical presentation, and outcomes of ischemic heart failure. Curr Heart Fail Rep. 2012;9(4):267–276. doi: 10.1007/s11897-012-0107-7. PubMed DOI PMC

Domengé O, Ragot H, Deloux R, Crépet A, Revet G, Boitard SE, Simon A, Mougenot N, David L, Delair T, Montembault A, Agbulut O. Efficacy of epicardial implantation of acellular chitosan hydrogels in ischemic and nonischemic heart failure: impact of the acetylation degree of chitosan. Acta Biomater. 2021;119:125–139. doi: 10.1016/j.actbio.2020.10.045. PubMed DOI

Yan W, Lin C, Guo Y, Chen Y, Du Y, Lau WB, Xia Y, Zhang F, Su R, Gao E, Wang Y, Li C, Liu R, Ma XL, Tao L. N-cadherin overexpression mobilizes the protective effects of mesenchymal stromal cells against ischemic heart injury through a β-catenin-dependent manner. Circ Res. 2020;126(7):857–874. doi: 10.1161/CIRCRESAHA.119.315806. PubMed DOI

Ali A, Wang Y, Wu L, Yang G. Gasotransmitter signaling in energy homeostasis and metabolic disorders. Free Radic Res. 2021;55(1):83–105. doi: 10.1080/10715762.2020.1862827. PubMed DOI

Pan LL, Liu XH, Gong QH, Yang HB, Zhu YZ. Role of cystathionine γ-lyase/hydrogen sulfide pathway in cardiovascular disease: a novel therapeutic strategy? Antioxid Redox Signal. 2012;17(1):106–118. doi: 10.1089/ars.2011.4349. PubMed DOI PMC

Hsu CN, Tain YL. Preventing developmental origins of cardiovascular disease: hydrogen sulfide as a potential target? Antioxidants (Basel) 2021;10(2):247. doi: 10.3390/antiox10020247. PubMed DOI PMC

Zhang H, Dai J, Tian D, Xiao L, Xue H, Guo Q, Zhang X, Teng X, Jin S, Wu Y. Hydrogen sulfide restored the diurnal variation in cardiac function of aging mice. Oxid Med Cell Longev. 2021;2021:8841575. doi: 10.1155/2021/8841575. PubMed DOI PMC

Donnarumma E, Trivedi RK, Lefer DJ. Protective actions of H2S in acute myocardial infarction and heart failure. Compr Physiol. 2017;7(2):583–602. doi: 10.1002/cphy.c160023. PubMed DOI

Calvert JW, Elston M, Nicholson CK, Gundewar S, Jha S, Elrod JW, Ramachandran A, Lefer DJ. Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice. Circulation. 2010;122(1):11–19. doi: 10.1161/CIRCULATIONAHA.109.920991. PubMed DOI PMC

Miao L, Xin X, Xin H, Shen X, Zhu YZ. Hydrogen sulfide recruits macrophage migration by integrin β1-Src-FAK/Pyk2-Rac pathway in myocardial infarction [published correction appears in Sci Rep. 2022 Feb 2, 12(1):2109] Sci Rep. 2016;6:22363. doi: 10.1038/srep22363. PubMed DOI PMC

Donnarumma E, Bhushan S, Bradley JM, Otsuka H, Donnelly EL, Lefer DJ, Islam KN. Nitrite therapy ameliorates myocardial dysfunction via h2s and nuclear factor-erythroid 2-related factor 2 (Nrf2)-Dependent Signaling in Chronic Heart Failure. J Am Heart Assoc. 2016;5(8):e003551. doi: 10.1161/JAHA.116.003551. PubMed DOI PMC

Kar S, Kambis TN, Mishra PK. Hydrogen sulfide-mediated regulation of cell death signaling ameliorates adverse cardiac remodeling and diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2019;316(6):H1237–H1252. doi: 10.1152/ajpheart.00004.2019. PubMed DOI PMC

Rasheed A, Robichaud S, Nguyen MA, Geoffrion M, Wyatt H, Cottee ML, Dennison T, Pietrangelo A, Lee R, Lagace TA, Ouimet M, Rayner KJ. Loss of MLKL (Mixed Lineage Kinase Domain-Like Protein) Decreases Necrotic Core but Increases Macrophage Lipid Accumulation in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2020;40(5):1155–1167. doi: 10.1161/ATVBAHA.119.313640. PubMed DOI

Ying L, Benjanuwattra J, Chattipakorn SC, Chattipakorn N. The role of RIPK3-regulated cell death pathways and necroptosis in the pathogenesis of cardiac ischaemia-reperfusion injury. Acta Physiol (Oxf) 2021;231(2):e13541. doi: 10.1111/apha.13541. PubMed DOI

Zhang Y, Li M, Li X, et al. Catalytically inactive RIP1 and RIP3 deficiency protect against acute ischemic stroke by inhibiting necroptosis and neuroinflammation. Cell Death Dis. 2020;11(7):565. doi: 10.1038/s41419-020-02770-w. PubMed DOI PMC

Luedde M, Lutz M, Carter N, Sosna J, Jacoby C, Vucur M, Gautheron J, Roderburg C, Borg N, Reisinger F, Hippe HJ, Linkermann A, Wolf MJ, Rose-John S, Lüllmann-Rauch R, Adam D, Flögel U, Heikenwalder M, Luedde T, Frey N. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovasc Res. 2014;103(2):206–216. doi: 10.1093/cvr/cvu146. PubMed DOI

Szobi A, Gonçalvesová E, Varga ZV, Leszek P, Kuśmierczyk M, Hulman M, Kyselovič J, Ferdinandy P, Adameová A. Analysis of necroptotic proteins in failing human hearts [published correction appears in J Transl Med 2017 May 11, 15(1):103] J Transl Med. 2017;15(1):86. doi: 10.1186/s12967-017-1189-5. PubMed DOI PMC

Koudstaal S, Oerlemans MI, Van der Spoel TI, Janssen AW, Hoefer IE, Doevendans PA, Sluijter JP, Chamuleau SA. Necrostatin-1 alleviates reperfusion injury following acute myocardial infarction in pigs. Eur J Clin Invest. 2015;45(2):150–159. doi: 10.1111/eci.12391. PubMed DOI

Kuhn TC, Knobel J, Burkert-Rettenmaier S, Li X, Meyer IS, Jungmann A, Sicklinger F, Backs J, Lasitschka F, Müller OJ, Katus HA, Krijgsveld J, Leuschner F. Secretome Analysis of Cardiomyocytes Identifies PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6) as a Novel Player in Cardiac Remodeling After Myocardial Infarction. Circulation. 2020;141(20):1628–1644. doi: 10.1161/CIRCULATIONAHA.119.044914. PubMed DOI

Tan B, Jin S, Sun J, Gu Z, Sun X, Zhu Y, Huo K, Cao Z, Yang P, Xin X, Liu X, Pan L, Qiu F, Jiang J, Jia Y, Ye F, Xie Y, Zhu YZ. New method for quantification of gasotransmitter hydrogen sulfide in biological matrices by LC-MS/MS. Sci Rep. 2017;7:46278. doi: 10.1038/srep46278. PubMed DOI PMC

Gabriel-Costa D. The pathophysiology of myocardial infarction-induced heart failure. Pathophysiology. 2018;25(4):277–284. doi: 10.1016/j.pathophys.2018.04.003. PubMed DOI

Mouton AJ, Rivera OJ, Lindsey ML. Myocardial infarction remodeling that progresses to heart failure: a signaling misunderstanding. Am J Physiol Heart Circ Physiol. 2018;315(1):H71–H79. doi: 10.1152/ajpheart.00131.2018. PubMed DOI PMC

Matsushima S, Ide T, Yamato M, Matsusaka H, Hattori F, Ikeuchi M, Kubota T, Sunagawa K, Hasegawa Y, Kurihara T, Oikawa S, Kinugawa S, Tsutsui H. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation. 2006;113(14):1779–1786. doi: 10.1161/CIRCULATIONAHA.105.582239. PubMed DOI

Pan Y, Zhou Z, Zhang H, Zhou Y, Li Y, Li C, Chen X, Yang S, Liao Y, Qiu Z. The ATRQβ-001 vaccine improves cardiac function and prevents postinfarction cardiac remodeling in mice. Hypertens Res. 2019;42(3):329–340. doi: 10.1038/s41440-018-0185-3. PubMed DOI

Bucholz EM, Butala NM, Rathore SS, Dreyer RP, Lansky AJ, Krumholz HM. Sex differences in long-term mortality after myocardial infarction: a systematic review. Circulation. 2014;130(9):757–767. doi: 10.1161/CIRCULATIONAHA.114.009480. PubMed DOI PMC

Tran BH, Huang C, Zhang Q, Liu X, Lin S, Liu H, Wang S, Zhu YZ. Cardioprotective effects and pharmacokinetic properties of a controlled release formulation of a novel hydrogen sulfide donor in rats with acute myocardial infarction. Biosci Rep. 2015;35(3):e00216. doi: 10.1042/BSR20140185. PubMed DOI PMC

Zhang Z, Jin S, Teng X, Duan X, Chen Y, Wu Y. Hydrogen sulfide attenuates cardiac injury in takotsubo cardiomyopathy by alleviating oxidative stress. Nitric Oxide. 2017;67:10–25. doi: 10.1016/j.niox.2017.04.010. PubMed DOI

Shimizu Y, Polavarapu R, Eskla KL, Nicholson CK, Koczor CA, Wang R, Lewis W, Shiva S, Lefer DJ, Calvert JW. Hydrogen sulfide regulates cardiac mitochondrial biogenesis via the activation of AMPK. J Mol Cell Cardiol. 2018;116:29–40. doi: 10.1016/j.yjmcc.2018.01.011. PubMed DOI PMC

Miao L, Shen X, Whiteman M, Xin H, Shen Y, Xin X, Moore PK, Zhu YZ. Hydrogen sulfide mitigates myocardial infarction via promotion of mitochondrial biogenesis-dependent M2 polarization of macrophages. Antioxid Redox Signal. 2016;25(5):268–281. doi: 10.1089/ars.2015.6577. PubMed DOI

Wu D, Hu Q, Xiong Y, Zhu D, Mao Y, Zhu YZ. Novel H2S-NO hybrid molecule (ZYZ-803) promoted synergistic effects against heart failure. Redox Biol. 2018;15:243–252. doi: 10.1016/j.redox.2017.11.020. PubMed DOI PMC

Kar S, Shahshahan HR, Kambis TN, Yadav SK, Li Z, Lefer DJ, Mishra PK. Hydrogen sulfide ameliorates homocysteine-induced cardiac remodeling and dysfunction. Front Physiol. 2019;10:598. doi: 10.3389/fphys.2019.00598. PubMed DOI PMC

Karwi QG, Whiteman M, Wood ME, Torregrossa R, Baxter GF. Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137. Pharmacol Res. 2016;111:442–451. doi: 10.1016/j.phrs.2016.06.028. PubMed DOI

Mishra PK, Adameova A, Hill JA, Baines CP, Kang PM, Downey JM, Narula J, Takahashi M, Abbate A, Piristine HC, Kar S, Su S, Higa JK, Kawasaki NK, Matsui T. Guidelines for evaluating myocardial cell death. Am J Physiol Heart Circ Physiol. 2019;317(5):H891–H922. doi: 10.1152/ajpheart.00259.2019. PubMed DOI PMC

Khoury MK, Gupta K, Franco SR, Liu B. Necroptosis in the pathophysiology of disease. Am J Pathol. 2020;190(2):272–285. doi: 10.1016/j.ajpath.2019.10.012. PubMed DOI PMC

Sun W, Wu X, Gao H, Yu J, Zhao W, Lu JJ, Wang J, Du G, Chen X. Cytosolic calcium mediates RIP1/RIP3 complex-dependent necroptosis through JNK activation and mitochondrial ROS production in human colon cancer cells. Free Radic Biol Med. 2017;108:433–444. doi: 10.1016/j.freeradbiomed.2017.04.010. PubMed DOI

Lichý M, Szobi A, Hrdlička J, Horváth C, Kormanová V, Rajtík T, Neckář J, Kolář F, Adameová A. Different signalling in infarcted and non-infarcted areas of rat failing hearts: A role of necroptosis and inflammation. J Cell Mol Med. 2019 Sep;23(9):6429–6441. doi: 10.1111/jcmm.14536. PubMed DOI PMC

Guo X, Yin H, Li L, Chen Y, Li J, Doan J, Steinmetz R, Liu Q. Cardioprotective role of tumor necrosis factor receptor-associated factor 2 by suppressing apoptosis and necroptosis. Circulation. 2017;136(8):729–742. doi: 10.1161/CIRCULATIONAHA.116.026240. PubMed DOI PMC

Zhang H, Yin Y, Liu Y, Zou G, Huang H, Qian P, Zhang G, Zhang J. Necroptosis mediated by impaired autophagy flux contributes to adverse ventricular remodeling after myocardial infarction. Biochem Pharmacol. 2020 May;175:113915. doi: 10.1016/j.bcp.2020.113915. PubMed DOI

Oerlemans MI, Liu J, Arslan F, den Ouden K, van Middelaar BJ, Doevendans PA, Sluijter JP. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. Basic Res Cardiol. 2012 Jul;107(4):270. doi: 10.1007/s00395-012-0270-8. PubMed DOI

Chang L, Wang Z, Ma F, Tran B, Zhong R, Xiong Y, Dai T, Wu J, Xin X, Guo W, Xie Y, Mao Y, Zhu YZ. ZYZ-803 Mitigates Endoplasmic Reticulum Stress-Related Necroptosis after Acute Myocardial Infarction through Downregulating the RIP3-CaMKII Signaling Pathway. Oxid Med Cell Longev. 2019;2019:6173685. doi: 10.1155/2019/6173685. PubMed DOI PMC

Lin J, Chen M, Liu D, Guo R, Lin K, Deng H, Zhi X, Zhang W, Feng J, Wu W. Exogenous hydrogen sulfide protects human umbilical vein endothelial cells against high glucose-induced injury by inhibiting the necroptosis pathway. Int J Mol Med. 2018;41(3):1477–1486. doi: 10.3892/ijmm.2017.3330. PubMed DOI PMC

Chi Q, Wang D, Hu X, Li S, Li S. Hydrogen Sulfide Gas Exposure Induces Necroptosis and Promotes Inflammation through the MAPK/NF-κB Pathway in Broiler Spleen. Oxid Med Cell Longev. 2019;2019:8061823. doi: 10.1155/2019/8061823. PubMed DOI PMC